Used in pharmaceutical research as a potent and selective inhibitor of kinases involved in cancer cell signaling pathways. It shows promise in targeting tumor growth and proliferation, particularly in hematologic malignancies. Its structure allows for high binding affinity to specific kinase targets, making it a candidate for development in targeted cancer therapies. Studies focus on its efficacy, pharmacokinetics, and potential use in combination with other anticancer agents.